PL4146244T3 - Kompozycje zawierające gelsolinę do leczenia osłabienia - Google Patents
Kompozycje zawierające gelsolinę do leczenia osłabieniaInfo
- Publication number
- PL4146244T3 PL4146244T3 PL21727690.6T PL21727690T PL4146244T3 PL 4146244 T3 PL4146244 T3 PL 4146244T3 PL 21727690 T PL21727690 T PL 21727690T PL 4146244 T3 PL4146244 T3 PL 4146244T3
- Authority
- PL
- Poland
- Prior art keywords
- gelsolin
- compositions
- treating frailty
- frailty
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063019482P | 2020-05-04 | 2020-05-04 | |
| PCT/US2021/030422 WO2021225937A1 (en) | 2020-05-04 | 2021-05-03 | Compositions comprising gelsolin for treating frailty |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4146244T3 true PL4146244T3 (pl) | 2026-04-07 |
Family
ID=76076487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21727690.6T PL4146244T3 (pl) | 2020-05-04 | 2021-05-03 | Kompozycje zawierające gelsolinę do leczenia osłabienia |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230158107A1 (pl) |
| EP (1) | EP4146244B1 (pl) |
| JP (1) | JP2023524604A (pl) |
| CN (1) | CN116322737A (pl) |
| AU (1) | AU2021268600A1 (pl) |
| CA (1) | CA3182149A1 (pl) |
| DK (1) | DK4146244T3 (pl) |
| ES (1) | ES3064057T3 (pl) |
| FI (1) | FI4146244T3 (pl) |
| PL (1) | PL4146244T3 (pl) |
| PT (1) | PT4146244T (pl) |
| WO (1) | WO2021225937A1 (pl) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5211657A (en) | 1988-11-07 | 1993-05-18 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| US8367356B2 (en) * | 2007-08-15 | 2013-02-05 | Beijing Cotimes Biotech Co., Ltd. | Gelsolin binding agent compositions and uses of same |
| EP2708603B1 (en) * | 2008-01-25 | 2017-04-19 | The General Hospital Corporation | Diagnostic and therapeutic uses of gelsolin in renal failure |
| AU2020296862B2 (en) * | 2019-06-21 | 2025-10-09 | Bioaegis Therapeutics Inc. | Compositions and synergistic methods for treating infections |
-
2021
- 2021-05-03 PL PL21727690.6T patent/PL4146244T3/pl unknown
- 2021-05-03 JP JP2023511878A patent/JP2023524604A/ja active Pending
- 2021-05-03 EP EP21727690.6A patent/EP4146244B1/en active Active
- 2021-05-03 PT PT217276906T patent/PT4146244T/pt unknown
- 2021-05-03 US US17/923,168 patent/US20230158107A1/en active Pending
- 2021-05-03 CN CN202180047389.3A patent/CN116322737A/zh active Pending
- 2021-05-03 WO PCT/US2021/030422 patent/WO2021225937A1/en not_active Ceased
- 2021-05-03 DK DK21727690.6T patent/DK4146244T3/da active
- 2021-05-03 CA CA3182149A patent/CA3182149A1/en active Pending
- 2021-05-03 AU AU2021268600A patent/AU2021268600A1/en active Pending
- 2021-05-03 FI FIEP21727690.6T patent/FI4146244T3/fi active
- 2021-05-03 ES ES21727690T patent/ES3064057T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT4146244T (pt) | 2026-02-26 |
| JP2023524604A (ja) | 2023-06-12 |
| US20230158107A1 (en) | 2023-05-25 |
| ES3064057T3 (en) | 2026-04-22 |
| EP4146244B1 (en) | 2025-11-26 |
| CA3182149A1 (en) | 2021-11-11 |
| AU2021268600A1 (en) | 2022-12-08 |
| EP4146244A1 (en) | 2023-03-15 |
| DK4146244T3 (da) | 2026-03-02 |
| CN116322737A (zh) | 2023-06-23 |
| FI4146244T3 (fi) | 2026-02-25 |
| WO2021225937A1 (en) | 2021-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261774B (en) | Preparations for the treatment of skin problems | |
| EP4256011C0 (en) | COMPOSITION | |
| GB202005911D0 (en) | Composition | |
| SG11202102942VA (en) | Compositions useful for treating gm1 gangliosidosis | |
| GB202004460D0 (en) | Herbical composition | |
| IL317433A (en) | Compounds for the treatment of XLMTM | |
| GB202018029D0 (en) | Composition | |
| GB202012895D0 (en) | Composition | |
| GB202319994D0 (en) | Compositions for use | |
| GB202016236D0 (en) | Composition | |
| GB202006093D0 (en) | Composition | |
| EP4259762C0 (en) | COMPOSITION | |
| GB202000619D0 (en) | Composition | |
| GB2608036B (en) | Compositions for the treatment of hemangioma | |
| EP4330363C0 (en) | COMPOSITION | |
| ZA202109732B (en) | Composition for prevention or treatment of hair loss including hapln1 | |
| IL287046A (en) | Solid pharmaceutical compounds for the treatment of HCV | |
| GB2605389B (en) | Composition | |
| GB202014635D0 (en) | Composition | |
| GB202003550D0 (en) | Composition | |
| IL263336B (en) | Compounds for the treatment of symphysiolysis | |
| GB202109297D0 (en) | Compositions for the treatment of hypopigmentation | |
| GB202202970D0 (en) | Composition for use | |
| GB202406302D0 (en) | Composition | |
| GB202118079D0 (en) | Composition |